Journal of Human Genetics and Genomics

Published by: Kowsar
Crossmark

The Association of V427M Missense Mutation of the PRODH Gene with Schizophrenia in the Iranian Patients

Seyedeh Sara Karimian 1 and Mohammad Taghi Akbari ORCID 2 , *
Authors Information
1 Department of Biology, Sciences and Research Branch, Islamic Azad University, Tehran, Iran
2 Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modarres University, Tehran, Iran
Article information
  • Journal of Human Genetics and Genomics: December 31, 2018, 2 (2); e83501
  • Published Online: December 19, 2018
  • Article Type: Research Article
  • Received: August 20, 2018
  • Accepted: November 3, 2018
  • DOI: 10.5812/jhgg.83501

How to Cite: Karimian S S, Akbari M T. The Association of V427M Missense Mutation of the PRODH Gene with Schizophrenia in the Iranian Patients, J Human Gen Genom. 2018 ; 2(2):e83501. doi: 10.5812/jhgg.83501.

Abstract
Copyright © 2018, Journal of Human Genetics and Genomics. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
Footnotes
References
  • 1. Levinson DF, Duan J, Oh S, Wang K, Sanders AR, Shi J, et al. Copy number variants in schizophrenia: Confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications. Am J Psychiatry. 2011;168(3):302-16. doi: 10.1176/appi.ajp.2010.10060876. [PubMed: 21285140]. [PubMed Central: PMC4441324].
  • 2. Pulver AE, Nestadt G, Goldberg R, Shprintzen RJ, Lamacz M, Wolyniec PS, et al. Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives. J Nerv Ment Dis. 1994;182(8):476-8. doi: 10.1097/00005053-199408000-00010. [PubMed: 8040660].
  • 3. Christofolini DM, Bellucco FT, Ota VK, Belangero SI, Cernach MC, Gadelha A, et al. Assessment of 22q11.2 copy number variations in a sample of Brazilian schizophrenia patients. Schizophr Res. 2011;132(1):99-100. doi: 10.1016/j.schres.2011.07.007. [PubMed: 21813265].
  • 4. Shaikh TH, Kurahashi H, Saitta SC, O'Hare AM, Hu P, Roe BA, et al. Chromosome 22-specific low copy repeats and the 22q11.2 deletion syndrome: Genomic organization and deletion endpoint analysis. Hum Mol Genet. 2000;9(4):489-501. doi: 10.1093/hmg/9.4.489. [PubMed: 10699172].
  • 5. Bender HU, Almashanu S, Steel G, Hu CA, Lin WW, Willis A, et al. Functional consequences of PRODH missense mutations. Am J Hum Genet. 2005;76(3):409-20. doi: 10.1086/428142. [PubMed: 15662599]. [PubMed Central: PMC1196393].
  • 6. Liu W, Phang JM. Proline dehydrogenase (oxidase), a mitochondrial tumor suppressor, and autophagy under the hypoxia microenvironment. Autophagy. 2012;8(9):1407-9. doi: 10.4161/auto.21152. [PubMed: 22885468]. [PubMed Central: PMC3442893].
  • 7. Liu H, Heath SC, Sobin C, Roos JL, Galke BL, Blundell ML, et al. Genetic variation at the 22q11 PRODH2/DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia. Proc Natl Acad Sci U S A. 2002;99(6):3717-22. doi: 10.1073/pnas.042700699. [PubMed: 11891283]. [PubMed Central: PMC122590].
  • 8. Jacquet H, Demily C, Houy E, Hecketsweiler B, Bou J, Raux G, et al. Hyperprolinemia is a risk factor for schizoaffective disorder. Mol Psychiatry. 2005;10(5):479-85. doi: 10.1038/sj.mp.4001597. [PubMed: 15494707].
  • 9. Gogos JA, Santha M, Takacs Z, Beck KD, Luine V, Lucas LR, et al. The gene encoding proline dehydrogenase modulates sensorimotor gating in mice. Nat Genet. 1999;21(4):434-9. doi: 10.1038/7777. [PubMed: 10192398].
  • 10. Paterlini M, Zakharenko SS, Lai WS, Qin J, Zhang H, Mukai J, et al. Transcriptional and behavioral interaction between 22q11.2 orthologs modulates schizophrenia-related phenotypes in mice. Nat Neurosci. 2005;8(11):1586-94. doi: 10.1038/nn1562. [PubMed: 16234811].
  • 11. Sawa A. Cortical development and glutamatergic dysregulation in schizophrenia. Biol Psychiatry. 2009;66(6):530-2. doi: 10.1016/j.biopsych.2009.07.016. [PubMed: 19712774]. [PubMed Central: PMC4113958].
  • 12. Ota VK, Bellucco FT, Gadelha A, Santoro ML, Noto C, Christofolini DM, et al. PRODH polymorphisms, cortical volumes and thickness in schizophrenia. PLoS One. 2014;9(2). e87686. doi: 10.1371/journal.pone.0087686. [PubMed: 24498354]. [PubMed Central: PMC3912045].
  • 13. Kempf L, Nicodemus KK, Kolachana B, Vakkalanka R, Verchinski BA, Egan MF, et al. Functional polymorphisms in PRODH are associated with risk and protection for schizophrenia and fronto-striatal structure and function. PLoS Genet. 2008;4(11). e1000252. doi: 10.1371/journal.pgen.1000252. [PubMed: 18989458]. [PubMed Central: PMC2573019].
  • 14. Bressan RA, Pilowsky LS. [Glutamatergic hypothesis of schizophrenia]. Braz J Psychiatr. 2003;25(3):177-83. Portuguese. doi: 10.1590/S1516-44462003000300011. [PubMed: 12975693].
  • 15. Rodriguez S, Gaunt TR, Day IN. Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies. Am J Epidemiol. 2009;169(4):505-14. doi: 10.1093/aje/kwn359. [PubMed: 19126586]. [PubMed Central: PMC2640163].
  • 16. Bassett AS, Chow EW. Schizophrenia and 22q11. 2 deletion syndrome. Curr Psychiatry Rep. 2008;10(2):148. doi: 10.1007/s11920-008-0026-1.
  • 17. du Bois TM, Huang XF. Early brain development disruption from NMDA receptor hypofunction: Relevance to schizophrenia. Brain Res Rev. 2007;53(2):260-70. doi: 10.1016/j.brainresrev.2006.09.001. [PubMed: 17014910].
  • 18. Farber NB, Kim SH, Dikranian K, Jiang XP, Heinkel C. Receptor mechanisms and circuitry underlying NMDA antagonist neurotoxicity. Mol Psychiatry. 2002;7(1):32-43. doi: 10.1038/sj/mp/4000912. [PubMed: 11803444].
  • 19. Theberge J, Bartha R, Drost DJ, Menon RS, Malla A, Takhar J, et al. Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers. Am J Psychiatry. 2002;159(11):1944-6. doi: 10.1176/appi.ajp.159.11.1944. [PubMed: 12411236].
  • 20. Kitzinger H, Arnold DG; et al. A preliminary study of the effects of glutamic acid on catatonic schizophrenics. Rorschach Res Exch J Proj Tech. 1949;13(2):210-8. doi: 10.1080/10683402.1949.10381459. [PubMed: 18137723].
  • 21. Sokolov BP. Expression of NMDAR1, GluR1, GluR7, and KA1 glutamate receptor mRNAs is decreased in frontal cortex of "neuroleptic-free" schizophrenics: Evidence on reversible up-regulation by typical neuroleptics. J Neurochem. 1998;71(6):2454-64. doi: 10.1046/j.1471-4159.1998.71062454.x. [PubMed: 9832144].
  • 22. Hammond J, Shan D, Meador-Woodruff J, McCullumsmith R. Evidence of glutamatergic dysfunction in the pathophysiology of schizophrenia. Synaptic stress and pathogenesis of neuropsychiatric disorders. Springer; 2014. p. 265-94.
  • 23. Funk AJ, Rumbaugh G, Harotunian V, McCullumsmith RE, Meador-Woodruff JH. Decreased expression of NMDA receptor-associated proteins in frontal cortex of elderly patients with schizophrenia. Neuroreport. 2009;20(11):1019-22. doi: 10.1097/WNR.0b013e32832d30d9. [PubMed: 19483657]. [PubMed Central: PMC3731946].
  • 24. Schizophrenia Working Group of the Psychiatric Genomics C. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511(7510):421-7. doi: 10.1038/nature13595. [PubMed: 25056061]. [PubMed Central: PMC4112379].
  • 25. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry. 1994;51(3):199-214. doi: 10.1001/archpsyc.1994.03950030035004. [PubMed: 8122957].
  • 26. Morgan CJ, Curran HV. Acute and chronic effects of ketamine upon human memory: A review. Psychopharmacology (Berl). 2006;188(4):408-24. doi: 10.1007/s00213-006-0572-3. [PubMed: 17006715].
  • 27. Javitt DC. Glutamate and schizophrenia: Phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions. Int Rev Neurobiol. 2007;78:69-108. doi: 10.1016/S0074-7742(06)78003-5. [PubMed: 17349858].
  • 28. Rahman Zadeh S, Shahbaz Mohammadi H, Karimipour M, Heidari Keshel S. Investigation of genetic association between PRODH gene and schizophrenia in Iranian population. J Paramed Sci. 2012;3(1):2916.
  • 29. Ghasemvand F, Salehi Z, Fakour Y, Omidinia E. Association of 757 C/T polymorphismin PRODH gene with schizophrenia in Iranian population. J Paramed Sci. 2013;4(1).
  • 30. Ghasemvand F, Omidinia E, Salehi Z, Rahmanzadeh S. Relationship between polymorphisms in the proline dehydrogenase gene and schizophrenia risk. Genet Mol Res. 2015;14(4):11681-91. doi: 10.4238/2015.October.2.1. [PubMed: 26436492].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments